ASAN FOUNDATION
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers
Phase 2
Recruiting
- Conditions
- Subjects With Resectable Liver CancerSubjects With Resectable and Localized Gastric CancerSubjects With Resectable Esophageal Cancer or Liver Cancer
- Interventions
- Drug: IMC-001
- First Posted Date
- 2019-12-12
- Last Posted Date
- 2019-12-12
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 48
- Registration Number
- NCT04196465
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
The Study for the Reliability and Validity of Incremental Shuttle Walking Test for COPD Patients in Korea
Not Applicable
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Diagnostic Test: Exercise stress testDiagnostic Test: 6 minutes walking testDiagnostic Test: Shuttle walking test
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT04178278
- Locations
- π°π·
Asan Medical Center, University of Ulsan College of Medicine, Seoul, Songpa, Korea, Republic of
Effect of Papaverine on Renal Artery Blood Flow Volume
- First Posted Date
- 2019-11-14
- Last Posted Date
- 2021-04-19
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 96
- Registration Number
- NCT04162834
- Locations
- π°π·
Asan medical Center, Seoul, Korea, Republic of
Usefulness of the Artery First Approach in Pancreatic Cancer Surgery
Not Applicable
- Conditions
- Margin, Tumor-FreeRecurrence TumorPancreatic Cancer, AdultSurgery Site Fistula
- Interventions
- Procedure: total mesopancreas excision including superior mesenteric artery first approachProcedure: conventional pancreaticoduodenectomy
- First Posted Date
- 2019-10-23
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 268
- Registration Number
- NCT04136522
- Locations
- π°π·
Asan medical center, Seoul, Korea, Republic of
Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer
Completed
- Conditions
- Pancreatic CancerMetastatic Pancreatic Cancer
- Interventions
- First Posted Date
- 2019-10-21
- Last Posted Date
- 2020-03-13
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 103
- Registration Number
- NCT04133155
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Radiogenomic and Prognosis Analysis in Glioma
- Conditions
- Glioma
- Interventions
- Diagnostic Test: MRI
- First Posted Date
- 2019-10-10
- Last Posted Date
- 2020-02-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 62
- Registration Number
- NCT04122521
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Diagnostic Yield of Deep Learning Based Denoising MRI in Cushing's Disease
Terminated
- Conditions
- Pituitary ACTH Secreting Adenoma
- Interventions
- Diagnostic Test: MRI
- First Posted Date
- 2019-10-10
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT04121988
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Effect of 25-OH-vitamin D3 on the Liver Transplant Recipients
Completed
- Conditions
- Liver Transplant Disorder
- First Posted Date
- 2019-10-01
- Last Posted Date
- 2019-10-01
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 219
- Registration Number
- NCT04111146
- Locations
- π°π·
Hakjae Lee, Seoul, Korea, Republic of
Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer
Not Applicable
- Conditions
- Chemotherapy EffectGenetic ChangePancreatic Cancer
- Interventions
- Diagnostic Test: next generation sequencingDiagnostic Test: following next generation sequencing
- First Posted Date
- 2019-10-01
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT04110769
- Locations
- π°π·
Asan medical center, Seoul, Korea, Republic of
Environmental Intervention on Delirious Patients
Not Applicable
Completed
- Conditions
- Delirium
- Interventions
- Behavioral: environmental intervention
- First Posted Date
- 2019-08-02
- Last Posted Date
- 2019-08-05
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 192
- Registration Number
- NCT04042649
- Locations
- π°π·
Hakjae Lee, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath